Norelitai Biopharmaceutical Technology (Shanghai) Co., Ltd – Trademark Portfolio
Entity Type: 16
Norelitai Biopharmaceutical Technology (Shanghai) Co., Ltd holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 1 trademark is registered. Notable registered marks include RUBURERE. The owner is based in Shanghai.
Fengjing Economic Development Zone
No. 11, Lane 65,Huandong 1st Road
Shanghai 201501 , CN
Showing of trademarks Trademarks
Trademark Classifications
Norelitai Biopharmaceutical Technology (Shanghai) Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Norelitai Biopharmaceutical Technology (Shanghai) Co., Ltd have?
Norelitai Biopharmaceutical Technology (Shanghai) Co., Ltd has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does Norelitai Biopharmaceutical Technology (Shanghai) Co., Ltd file in?
Norelitai Biopharmaceutical Technology (Shanghai) Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Norelitai Biopharmaceutical Technology (Shanghai) Co., Ltd's most well-known trademarks?
Norelitai Biopharmaceutical Technology (Shanghai) Co., Ltd's registered trademark portfolio includes well-known marks such as RUBURERE. These are among 1 currently registered trademark in the portfolio.
What is Norelitai Biopharmaceutical Technology (Shanghai) Co., Ltd's trademark registration success rate?
Norelitai Biopharmaceutical Technology (Shanghai) Co., Ltd has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.